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Abstract
Uncoupling protein-2 (UCP2) is a member of the inner mitochondrial membrane anion-carrier superfamily. Although mRNA for UCP2 is
widely expressed, protein expression is detected in only a few cell types, including macrophages. UCP2 functions by an incompletely defined
mechanism, to reduce reactive oxygen species production during mitochondrial electron transport. We observed that the abundance of UCP2 in
macrophages increased rapidly in response to treatments (rotenone, antimycin A and diethyldithiocarbamate) that increased mitochondrial
superoxide production, but not in response to superoxide produced outside the mitochondria or in response to H2O2. Increased UCP2 protein was
not accompanied by increases in ucp2 gene expression or mRNA abundance, but was due to enhanced translational efficiency and possibly
stabilization of UCP2 protein in the inner mitochondrial membrane. This was not dependent on mitochondrial membrane potential. These findings
extend our understanding of the homeostatic function of UCP2 in regulating mitochondrial reactive oxygen production by identifying a feedback
loop that senses mitochondrial reactive oxygen production and increases inner mitochondrial membrane UCP2 abundance and activity. Reactive
oxygen species-induction of UCP2 may facilitate survival of macrophages and retention of function in widely variable tissue environments.
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Uncoupling proteins belong to the superfamily of inner
mitochondrial membrane anion-carrier proteins that also
includes the adenine nucleotide translocases (ANT's) and the
phosphate, oxoglutarate/malate, carnitine, citrate, ornithine andAbbreviations: UCP2, Uncoupling protein-2; ANT, adenine nucleotide
translocase; UCP1, uncoupling protein-1; O2
S−, superoxide;Δψm, mitochondrial
membrane potential; TIM, transporter of inner mitochondrial membrane;
DMEM, Dulbecco's Modified Eagle Medium; FCS, foetal calf serum; BMM,
murine bone marrow-derived monocyte/macrophages; ROS, reactive oxygen
species; HBSS, Hanks balanced salt solution; DETC, diethyldithiocarbamate;
JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazol carbocyanine
iodide; CCCP, carbonyl cyanide m-chlorophenylhydrazone: 6-carboxy-
H2DCF-DA-AM, 6-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, di
(acetoxymethyl ester); DHE, dihydroethidium; Et, ethidium; DMNQ, 2, 3-
dimethoxy-1, 4-naphthoquinone
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doi:10.1016/j.bbabio.2007.11.006dicarboxylate carriers [1]. The first described uncoupling
protein family member, uncoupling protein-1 (UCP1) [2,3], is
expressed solely in the inner mitochondrial membrane of brown
adipose tissue at sufficiently high levels to be responsible for
thermogenesis [4,5]. Uncoupling protein-2 (UCP2) is expressed
widely in tissues and cell types [6,7] but in amounts too low to
be involved in thermoregulation [6,8–10].
UCP2 is best characterized as a regulator of reactive oxygen
species during electron transport in the mitochondrial inner
membrane. During normal mitochondrial respiration, a propor-
tion of electrons transferring between coenzyme Q and complex
I or complex III divert to reducing molecular oxygen to super-
oxide (O2
U−). Further steps of reduction can yield hydrogen
peroxide and the highly reactive hydroxyl radical [11]. Inter-
action between reactive oxygen species and biological mole-
cules can then generate a range of nitrogen- and carbon-centred
radical species and modified proteins and lipids. Systems of low
molecular weight reductants, sulfhydryl-containing protein re-
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chondria to detoxify reactive oxygen species.
Increased electron “leakage” to O2
U− production occurs when
electron transfer is slowed at complexes I and III [12–16], either
through the action of inhibitors at these sites (such as rotenone
and antimycin A, respectively) or because of elevated mito-
chondrial membrane potential (Δψm). The Δψm reflects the
pumping of protons from the matrix side of the inner mito-
chondrial membrane to the intermembrane side at complexes I,
III and IV. The backflow of protons through F0/F1 ATPase
generates ATP, a process that is normally in tight energetic
coupling with electron transport. Mitochondrial O2
U− production
is non-linearly increased when proton pumping forces Δψm
more negative than approximately −150mV [12,13,17]. Under
these circumstances, mild uncoupling of the electron transport
chain of the inner mitochondrial membrane dramatically re-
duces O2
U− production [18,19].
The primary function of the brown fat uncoupling protein,
UCP1, is to provide a proton channel that returns protons to the
mitochondrial matrix, so oxidative metabolism yields heat,
rather than ATP. In-vitro, UCP2 likewise serves to dissipate
transmembrane proton gradients, though the exact mechanism
is incompletely defined. UCP2 expression in the inner mito-
chondrial membrane lowers mitochondrial O2
U− production,
consistent with a mild uncoupling function [20]. Increased
mitochondrial reactive oxygen species production thus occurs in
macrophages of homozygous ucp2 gene-deleted mice [8].
Conversely, tissue-specific overexpression of UCP2 in pancrea-
tic beta islet cells lowers mitochondrial reactive oxygen pro-
duction [21]. Isolated cells of various lineages have shown
similar results [18,22,23].
UCP2 regulation of reactive oxygen species in macrophages
is notable. Macrophages exist as resident or inflammatory
populations in environments with widely varying nutrient avail-
ability and oxygenation. Resident alveolar macrophages experi-
ence O2 tensions exceeding other tissues, whereas tumor-
associatedmacrophages remain functional at the lowO2 tensions
that characterize hypoxic areas of tumor [24–26]. There is a
corresponding variation in dependence on oxidative phospho-
rylation and, it follows, different potential for mitochondrial
reactive oxygen species generation [27]. Alternate aerobic
energy sources include glucose, glutamine and fatty acids.
Under hypoxic conditions, anaerobic glycolysis supplies ATP
requirements [24,28]. Macrophages at sites of chronic inflam-
mation are also exposed to reactive oxygen species produced at
the surface NADPH oxidases of activated cells of the myelo-
monocytic lineage, including macrophages themselves [29].
It is therefore reasonable to inquire whether macrophages
have a particular need for flexible regulation of Δψm, so as to
keep mitochondrial reactive oxygen species production within
physiological bounds. This could be achieved if UCP2 activity
or abundance varied in reaction to mitochondrial reactive
oxygen species production. Functionally, O2
U− and reactive
oxygen species-derived products of lipid peroxidation, such as
4-hydroxynonenal do promote UCP2 uncoupling activity in
isolated membrane preparations [16,18,30,31]. There is now
also evidence that UCP2 abundance may vary in response tooxidative stress: an increase of 12-fold in UCP2 protein
expression in murine lung after exposure to gram-negative
bacterial lipopolysaccharide was attributed to oxidative stress [6].
ucp2 is encoded in the nuclear genome. Transcriptional
regulation has been described and extensively studied, but it is
clear that post-transcriptional events also strongly influence
protein abundance [32]. For example, the increase in pulmonary
UCP2 protein that followed lipopolysaccharide exposure was
not accompanied by an increase in mRNA expression [6]. Early
studies of UCP2 message levels in tissues have also proved
poorly predictive of protein expression [7,33]. Importation of
UCP2 into mitochondrial inner membrane and degradation are
also potentially regulable processes. Little is known about these.
UCP2 lacks identified mitochondrial targeting sequences and
has not yet been shown to be a substrate for the transporter of
inner mitochondrial membrane (TIM) proteins.
Evidence for UCP2 regulation in response to oxidative stress
in lung, coupled with evidence that UCP2 diminishes mito-
chondrial production of oxidizing radicals in macrophages
[8,23] suggests that macrophages might regulate expression of
UCP2 to cope with changes in nutrient availability, oxygenation
and oxidative stress in their environment. We therefore mea-
sured the effects of mitochondrial oxidative stress on the ex-
pression of UCP2 and explored the mechanism of regulation.
2. Materials and methods
2.1. Cell lines and reagents
The murine macrophage cell line, RAW264.7, was obtained from American
Type Culture Collection (ATCC). Cells were maintained in Dulbecco's Modified
Eagle Medium (DMEM) (Life Technologies, Melbourne, Australia) supple-
mented with 5% low endotoxin foetal calf serum (FCS) (CSL, Melbourne,
Australia), penicillin and gentamicin (DMEM/FCS). Cells were incubated in
DMEM/FCS in a humidified atmosphere of 5% CO2/95% air at 37 °C. Primary
murine bone marrow-derived monocyte/macrophages (BMM) were isolated
from long bones of C57/BL mice, as previously described [34], and expanded in
25cm2 culture flasks for 7days in DMEM/FCS supplemented with 50ng/ml of
humanmacrophage-colony stimulating factor (R&D Systems). The mediumwas
replaced on the 4th day. Cells were then treated as for RAW264.7 cells.
Reagents were supplied by Sigma, except where indicated.
2.2. Cell fractionation and protein analyses
RAW264.7 cells at 80% confluence in 25cm
2 flasks were exposed to rotenone
(10μM), the Cu/Zn superoxide dismutase inhibitor, diethyldithiocarbamate
(DETC: 0.3mM), antimycin A (10 μM), the site III inhibitor myxothiazole
(10μM) or the cytosolic redox-cycling agent, 2,3-dimethoxy-1,4-naphthoqui-
none (DMNQ: 10μM). After incubation, medium was removed and cultures
were placed on ice and washed with ice-cold Dulbecco's Phosphate Buffered
Saline. Whole cell extracts were made in RIPA buffer containing Complete
Protease Inhibitors (Roche). Cells for mitochondrial fractionation were scraped
into ice-cold TES buffer (10mM Tris, 1mM EDTA, 250mM sucrose pH 7.5)
containing protease inhibitors. Cells were collected by centrifugation and then
sequentially homogenized in ice-cold TES buffer using a Dounce homogenizer
and passed through a 30g needle. The homogenate was centrifuged at 750g
for 10min at 4 °C. The resulting supernatant was centrifuged again at 11,000g
for 30min at 4 °C to obtain the mitochondria-enriched pellet. The mito-
chondrial pellet was washed in cold TES buffer and re-centrifuged, to remove
contamination of membrane fractions. The final pellet was resuspended in
RIPA buffer containing protease inhibitors and stored at −20 °C. Inclusion of
EDTA in buffers limits the binding of polysomes, which may be in asso-
ciation with nascent UCP2, to mitochondria [35].
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teins, the mitochondrial fractions were incubated with digitonin (0.4mg/mg of
mitochondrial protein) and TES buffer on ice for 15min [36]. The mitoplast and
membrane fraction was separated from the fraction containing the inter-
membrane space proteins by centrifugation at 11,000g for 15min at 4 °C. The
mitoplast pellet was washed in TES buffer and centrifuged once again. The final
mitoplast pellet was lysed in RIPA buffer containing Roche Complete Protease
Inhibitor and stored at−20 °C. The supernatant was transferred to a Beckman
1.5ml Polyallomer Microfuge® Tube and centrifuged at 100,000g for 40min at
4 °C in a TL-100 ultracentrifuge (Beckman) equipped with a TLA45 rotor, to
sediment remaining membrane material. The supernatant containing the
intermembrane fraction was removed and stored at −20 °C.
Whole cell and mitochondrial fraction extracts (30–100μg total protein)
were separated by SDS-10% polyacrylamide gel electrophoresis, transferred
onto PVDFmembrane and probed with specific antibodies to UCP2 (Santa Cruz
Biotechnology, Santa Cruz, CA; sc-6526) and β-actin (Sigma, St. Louis, MO;
A-5441). A goat anti-UCP2 polyclonal antibody (sc-6526; 1:1000 dilution),
followed by anti-goat HRP IgG (Santa Cruz, sc-2020; 1:10,000) was used to
detect UCP2. β-actin was detected using a mouse monoclonal anti-β-actin
antibody (Sigma, A-5441; 1:10,000 dilution), followed by anti-mouse HRP IgG
antibody (Sigma, A-2554); 1:10,000). Porin1 (VDAC1) was detected using a
goat antibody (Santa Cruz, 8828; 1:1000 dilution), followed by anti-goat HRP
IgG antibody (Santa Cruz, sc-2020; 1:5000). The resolved bands were
visualized by enhanced chemiluminescence (ECL) detection reagents (Amer-
sham) and exposed to Hyperfilm ECL (Amersham) for 0.5–5min. Densitometric
quantitation of X-ray film was performed using Kodak Molecular Imaging
Software, Version 4.0 (Kodak). Statistical analysis of treatment effects on UCP2
expression employed data that was normalised for β-actin expression.
The specificity of the anti-UCP2 antibody was confirmed by transiently
expressing UCP2 in HEK 293 cells to generate a verified standard. To create the
expression vector for UCP2, the coding region was amplified from rat cDNA
using the primers (sense) 5′-GGTACCATGGTTGGTTTCAAGGCCACCGA-
TGTGCC-3′ and (antisense) 5′-GAGCTCAGTTTTCCCCACGGAGGGCCC-
TAAGTAT-3′. The restriction sites Kpn1 and Xho1 (underlined) were used for
ligation (LigaFast ligation system [Promega]) into the multiple cloning region of
pcDNA3.1 (Invitrogen). The vector was confirmed by sequencing. Rat UCP2
differs from murine UCP2 by two conservative amino acid substitutions. HEK
293 cells transiently transfected with the parent vector did not contain a protein
that was detectable with the antibody (Fig. 3A).
2.3. Transcription studies
To examine the regulation of UCP2 gene transcription, a fragment
corresponding to bases − 2746 to +100 of the UCP2 gene (Pubmed accession
NM_011671) was amplified from murine genomic DNA using the primers
(sense) 5′-CGCGGTACCACACACTAGCCTCCAGGACC-3′ and (antisense)
5′-ATGAACGCGTGAGAACACAGGAGTGCAGAA-3′. The underlined
sequences indicate KpnI and MluI sites required for cloning into the expression
system. The fragment was ligated into the multiple cloning site of the pGL3-
basic luciferase expression vector (Promega). The vectors were verified by
sequencing. The pGL3-basic vector was used as control.
For transient transfection, adherent RAW264.7 cells (approximately 10
7) were
released by trypsin exposure, pelleted in DMEM/FCS by centrifuging at 300g
for 5min, and resuspended in 750μl of antibiotic-free RPMI (Life Technologies)
containing 20mM HEPES pH 7.4. Cells were then transfected according to a
DEAE-Dextran protocol, as previously described [37]. Transfected RAW264.7
cells were then transferred to 24 well cell culture plates (3.3×105cells/well) and
rested overnight before being exposed to the indicated agents. Cell lysates were
prepared and firefly luciferase expression was measured using the Promega
Luciferase Assay System, according to manufacturer's instructions.
2.4. mRNA analysis
RAW264.7 cells and primary macrophages (0.8×10
5 per well) were cultured
for 48h in 6 well cell culture plates before exposure to rotenone, antimycin A or
DETC. Total cellular RNA was isolated using RNeasy® Protect Mini Kit
(Qiagen) in accordance with the manufacturer's protocol. The Omniscript
Reverse Transcriptase Kit (Qiagen) was used to for first-strand cDNA synthesis.PCR reactions were completed using an iCycler iQ Multi-Color Real-Time PCR
Detection System (Bio-Rad) and SYBR Green PCR MasterMix (Bio-Rad)
containing the SYBR green fluorescent reporter and Taq polymerase for cDNA
amplification. Aliquots of sample cDNAs were used to create separate standard
curves for relative quantification of UCP2 and β-actin genes. Sample cDNAs
(equivalent of 5ng of total RNA) were amplified by target specific primers
for UCP2; (sense) 5′-GGGTCCACGCAGCCTCTACAATG-3′, (antisense) 5′-
TCCCTTCCTCTCGTGCAATGGTCT-3′ and β-actin; (sense) 5′-CCTGACG-
GACTACCTCATGAA-3′, (antisense) 5′-GATGCCACAGGATTCCATA-3′.
The specificity of individual primers was tested by end point PCR and validated
by detection through gel electrophoresis. Thermal profiles for the amplification
were: 95 °C for 3min, then 40 cycles of 95 °C for 10s and 58 °C for 30s. A melt
temperature gradient curve was also carried out on final reaction products to
ensure that a single product had formed. Each sample was normalized using its
β-actin content as internal reference, and data are expressed as relative
abundance of UCP2 mRNA over β-actin mRNA.
2.5. Mitochondrial membrane potential
RAW264.7 cells were seeded (2–5×10
4 per well) in DMEM/FCS in clear
96-well plates (Nunc) and after 42–48h loadedwith 1μg/ml 5,5′,6,6′-tetrachloro-
1,1′,3,3′-tetraethylbenzimidazol carbocyanine iodide (JC-1) in DMEM/FCS for
20min. JC-1 is a cationic cell-permanent dye that exhibits potential-dependent
accumulation in mitochondria. Mitochondrial membrane potential was estimated
from the ratio of red (590nm) to green (520nm) emission fluorescence (green
denoting a more depolarized state and red a more polarized state) under 485nm
excitation, using a fluorescence microplate reader (POLARstar OPTIMA, BMG,
Germany). Control conditions for these experiments included exposure to the
proton ionophore, carbonyl cyanide m-chlorophenylhydrazone (CCCP), which
depolarises Δψm and to the F0F1 ATPase inhibitor oligomycin, which hyper-
polarises Δψm.
2.6. Fluorescent detection of mitochondrial reactive oxygen species
(ROS)
Superoxide and H2O2 were measured in RAW264.7 and bone marrow
macrophages (2–5×104) that had been maintained in clear 96-well plates over
two days (42–48h) in DMEM/FCS. To estimate O2
S− production, cells were
loaded with dihydroethidium (DHE: 10μM; Invitrogen) for 15min in DMEM/
FCS and then transferred to Hanks balanced salt solution (HBSS), where the
conversion to ethidium (Et) was measured as emission at 590nm during
excitation at 540nm in a POLARstar OPTIMA microplate reader over 3h at 37
°C [38,39]. H2O2 generation was estimated from the accumulation of 6-carboxy-
DCF [38,39] in cells that had been loaded with 3μM 6-carboxy-2′,7′-dichlor-
odihydrofluorescein diacetate, di(acetoxymethyl ester) (6-carboxy-H2DCF-DA-
AM: Invitrogen C-2938) for 45min in HBSS before transfer to fresh HBSS for
measurement. 6-carboxy-DCF was measured as 520nm emission during 485nm
excitation over 3h at 37 °C.
2.7. Statistical analysis
Statistical differences between control and test groups were analysed by one-
way ANOVA and a post-hoc Newman–Keuls test or paired t-test as indicated in
the figure legends (SigmaStat, Jandel Scientific). All results presented are the
mean±S.E.M.3. Results
3.1. Inhibitors of mitochondrial complexes I and III,
superoxide dismutase inhibition and cytosolic redox-cycling
reagents increase reactive oxygen species in macrophages
Conversion of the probe dihydroethidium (DHE) to fluore-
scent ethidium (Et) was used to measure O2
U− generation in
murine macrophages. The mitochondrial electron transport
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bitor, antimycin A (10μM), increase O2
U− production in pri-
mary murine bone-marrow derived macrophages over 90 min
and in the RAW264.7 murine macrophage line over 3h (Fig.
1A). The Cu/Zn superoxide dismutase inhibitor diethyldithio-
carbamate (DETC) (0.3mM), the site III inhibitor myxothia-
zole (10μM) and the cytosolic redox-cycling 2,3-dimethoxy-
1,4-naphthoquinone (DMNQ) (10μM) likewise increased
ethidium signal (Fig. 1B). H2O2 production was measured in
parallel RAW264.7 cell cultures as generation of the fluorescentFig. 1. Inhibitors of mitochondrial complexes I and III, DMNQ and DETC increase O
O2
S− generation, as measured by ethidium fluorescence over 90 and 180 min in bone-m
RAW264.7 cells are means±S.E.M for over 25 independent experiments each for roten
data were obtained from 2 independent experiments for rotenone and 1 experiment fo
treated with reagent named on panel. (B) The cytosolic redox-cycling agent, DMNQ
myxothiazole (10 μM) likewise increase ethidium signal in RAW264.7 cells. Results
and 7 for DETC, each in quintuplicate. ⁎pb0.05 for comparison of treated and con6-carboxydichlorofluorescein (6-carboxy-DCF) after loading
with 6-carboxy-H2DCF-DA-AM [38,39]. H2O2 increased in
cells exposed to rotenone, antimycin A and DMNQ, consistent
with the further reduction or dismutation of the O2
U− (Fig. 2).
In the presence of DETC, 6-carboxy-DCF signal fell, in
keeping with inhibited dismutation of O2
U− to H2O2 (Fig. 2).
These findings give confidence that the ethidium signal
observed in these cells truly reflects O2
U− generation. Added
hydrogen peroxide (100μM) and glucose oxidase (10U/ml)
also increased 6-carboxy-DCF signal, as expected (Fig. 2).2
S− in macrophages. (A) Rotenone (10 μM) and antimycin A (10 μM) increased
arrow derived macrophages (BMM) and RAW264.7 cells respectively. Data from
one and antimycin A, ⁎pb0.05 for comparison of treated and control cells. BMM
r antimycin A. All conditions were tested in quintuplicate. –▪–: control; –○–:
(10 μM), the Cu/Zn SOD inhibitor, DETC (0.3 mM) and the site III inhibitor
are means±S.E.M for 3 independent experiments for DMNQ and myxothiazole
trol cells.
Fig. 2. Inhibitors of mitochondrial complex I and complex III and reagents that generate ROS in the cytosol increase H2O2 production in macrophages. Rotenone,
antimycin A and DMNQ increased generation of the H2O2, as estimated by generation of the fluorophore 6-carboxy-DCF. H2O2 (100 μM) added directly or generated
extracellularly by glucose oxidase (10 U/ml), also increased DCF signal. DETC inhibits dismutation of O2
S− to H2O2, reducing 6-carboxy-DCF signal. Data are
means±S.E.M for RAW264.7 macrophages of at least 7 independent experiments each for rotenone, antimycin A and DETC and 3 experiments each for DMNQ, H2O2
and glucose oxidase with each condition performed in quintuplicate. –▪–: control; –○–: treated with reagent named on panel. Concentrations of rotenone, antimycin
A, DMNQ and DETC were as in Fig. 1. ⁎pb0.05 for comparison of treated and control cells.
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U−, but not
increased cytosolic O2
U− or exogenous H2O2, associates with
increased UCP2 protein expression
Exposure to rotenone increased UCP2 protein expression in
primary murine macrophages (Fig. 3A) and RAW264.7 cells.
Increased expression was apparent by 30min and reached a peak
in RAW264.7 cells after 2 to 4h (Fig. 3B). Comparable elevations
were observed in RAW264.7 cells exposed to antimycin, DETC
and myxothiazole (Fig. 3B). All these treatments increase
mitochondrial O2
U− generation (Fig. 1A and B). DMNQ, which
produces O2
U− extracellularly and in the cytosol [40] failed to
increase UCP2 (Fig. 3C). LPS or TPA, both of which increase
O2
U− generation by surface NADPH oxidase also failed to alter
UCP2 expression (Fig. 3C).
Glucose oxidase generates H2O2 continuously in the
presence of glucose, without increasing mitochondrial reactive
oxygen species production. Neither glucose oxidase nor bolus
addition of H2O2 altered UCP2 expression (Fig. 3C).
We had therefore observed that increased UCP2 protein
expression accompanied each of the treatments that increased
mitochondrial O2
U− production, but did not accompany treat-
ments that increased O2
U− or H2O2 generation elsewhere in thecell, or extracellularly. We therefore went on to investigate the
mechanism underlying the regulation.
3.3. Increased mitochondrial O2
U− generation is not
accompanied by increased ucp2 promoter activity or an
increase in UCP2 mRNA
RAW264.7 cells were transfected with a reporter vector
construct that incorporated the −2764 to +100 sequence of
the UCP2 promoter upstream of the luciferase coding se-
quence, as described in Methods. Cells were then exposed to
stimuli that increased mitochondrial O2
U− production and
luciferase activity was measured for up to 6h. None of the
treatments increased ucp2 promoter activity (Fig. 4A). At late
time points, when UCP2 protein was clearly increased
(Fig. 3B), rotenone-, antimycin A- and DETC-exposed
cultures had lost ucp2 promoter activity. ATP levels were
comparable in treated and control cultures, indicating pre-
served viability over 6h (results not shown). We concluded
that increased UCP2 expression was not due to any effect on
ucp2 transcription.
The effect of increased mitochondrial O2
U− production on
overall abundance of UCP2 mRNA was then examined with
Fig. 3. Increased UCP2 protein expression follows increased mitochondrial O2
S− production, but not O2S− or H2O2 production elsewhere in the cell or extracellularly.
(A) HEK 293 cells transiently transfected with an expression vector that coded for rat UCP2 express a protein of the size of UCP2 that is recognized by a specific
antibody. The same band is inducible in primary murine bone marrow-derived macrophages exposed to 10 μM rotenone for 6 h. Results are representative of 2
independent experiments in each case. (B) Rotenone, antimycin A, DETC and myxothiazole increase UCP2 expression at the same concentrations that increased O2
S−
generation in Fig. 1. Left panels show representative western analyses. Right panels show relative UCP2 band densities in western analyses of extracts from rotenone-
(n=12), antimycin A- (n=5), DETC- (n=4) and myxothiazole- (n=2) treated cells, compared with controls. UCP2 density was referenced to β-actin density at each
point. ⁎pb0.05 for comparison of treated and control cells. (C) Reagents that increase O2
S− generation extracellularly or elsewhere in the cell (DMNQ, LPS and TPA)
and agents that increase H2O2 (glucose oxidase, H2O2) fail to increase UCP2 over 2 h, at any concentration tested. Results are representative blots of 2 independent
experiments for DMNQ, H2O2, glucose oxidase (GO), LPS and TPA. Experiments that extended observations to 8 h with DMNQ (10 μM), H2O2 (100 μM), glucose
oxidase (10 U/ml), LPS (10 μg/ml) and TPA (10 μg/ml) also found no increase in UCP2 (results not shown).
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described in Methods. β-actin mRNA served as the internal
standard. Rotenone failed to increase the abundance of UCP2mRNA over 6h in either primary macrophages or RAW264.7
cells (Fig. 4B). Antimycin A and DETC similarly failed to
increase UCP2 mRNA in RAW264.7 cells (Fig. 4B).
Fig. 4. Increased mitochondrial O2
S− generation is not accompanied by increased ucp2 promoter activity or UCP2 mRNA. (A) Reagents that increase mitochondrial
O2
S− production did not increase transcriptional activity of a reporter vector construct that incorporates the −2764 to +100 base pair promoter region of the ucp2 gene,
transiently transfected into RAW264.7 cells. Results are shown as mean±S.E.M for 3 or 4 independent experiments for each reagent, over 6 h of reagent exposure.
Reagent concentrations were as for Fig. 1. Results are expressed as a ratio of luciferase activity in control cultures. (B) Rotenone failed to increase the abundance of
UCP2 mRNA (top panels) over 4 h in either primary macrophages (left panel) or RAW264.7 cells (right panel) respectively. DETC and antimycin A similarly failed to
increase UCP2 mRNA of RAW264.7 cells (bottom panels). UCP2 mRNAwas estimated by RT-PCR. Results are shown as mean±S.E.M for 3 independent experiments
for each reagent and expressed as fold-increase over abundance in control cultures.
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U− was
not increasing UCP2 through increasing transcription or
stability of UCP2 mRNA.
3.4. UCP2 accumulates in the mitochondrial inner membrane
during increased O2
U− generation
UCP2 is encoded in the nuclear genome. The protein is
expressed in the inner mitochondrial membrane. In common
with other members of its superfamily, UCP2 lacks a recognized
mitochondrial targeting sequence. The pathways for introduc-tion into the mitochondrial inner membrane and the pathways of
degradation are largely unknown.
We therefore examined whether UCP2 protein stabilization
was associated with enhanced accumulation in the inner
mitochondrial membrane. RAW264.7 cells were therefore treated
with rotenone, antimycin A or DETC, and cells were collected
for fractionation at 2h. Whole cell, mitochondria-enriched
fraction, inner mitochondrial membrane (mitoplast) and inter-
membrane space fractions were prepared, as described in
Methods. The recovery of mitochondrial protein was similar
in control, rotenone-treated, antimycin A-treated and DETC-
Fig. 5. UCP2 accumulates in the inner mitochondrial membrane (mitoplast
fraction) of RAW264.7 cells during periods of increased mitochondrial O2
S−
generation. Cells were treated for 2 h with rotenone (10 μM), antimycin A
(10 μM) or DETC (0.3 mM). Results are representative of 7 repetitions with
rotenone, all giving the same result. Antimycin A and DETC were tested once
each. Equivalent amounts of protein (100 μg) were separated in each lane. The
mitochondrial protein, porin was measured as a loading control to permit
comparisons of whole mitochondrial and mitoplasts preparations under various
conditions of stimulation. Extracts of untreated whole cells and rotenone-treated
whole cells were run in the left-most and right-most lanes, respectively.
125T.M. Giardina et al. / Biochimica et Biophysica Acta 1777 (2008) 118–129treated cells (mean recoveries of 102μg, 94μg, 126μg and
133μg per 107cells, respectively). In control cells, UCP2 was
detected in preparations of mitochondria-enriched fraction and
mitoplasts, and not in the intermembrane space, as expected
(Fig. 5). Treatment with rotenone, antimycin A or DETC each
greatly increased abundance in the mitochondria-enriched
fraction and in the mitoplasts fraction, but not in the inter-
membrane space (Fig. 5). These observations indicate that the
increased expression of UCP2 that associates with increased
mitochondrial O2
U− generation arises from an accumulation of
UCP2 in the inner mitochondrial membrane, where it can act to
regulate Δψm and thereby regulate O2
U− generation.
3.5. Induction of UCP2 during mitochondrial O2
U− generation
requires de-novo protein synthesis and is mediated though
increased synthesis and possibly also protein stabilization
Previous experiments had shown that the increase in UCP2
protein occurred without an increase in UCP2 mRNA, implying
an action on translation, recruitment to mitochondria or protein
stability. In an attempt to distinguish enhanced protein synthesis
from inhibited degradation, we measured the degradation rate of
UCP2 in RAW264.7 cells that had been exposed to rotenone,
antimycin A or DETC for 2h before protein translation was
halted by cycloheximide. UCP2 protein levels were measured
by western analysis for a further 2h (Fig. 6A and B) Normally,
UCP2 abundance in rotenone, antimycin A or DETC-exposed
cultures continues to rise above control cultures during this
time. However we observed that, when protein synthesis was
blocked, UCP2 abundance in rotenone-, antimycin A-, and
DETC-exposed cultures declined in parallel with controls
preparations, indicating that UCP2 abundances did not continue
to diverge in the absence of ongoing protein synthesis. Since
rotenone, antimycin A and DETC do not increase UCP2
mRNA, this implies that they act, at least partly, by enhancing
UCP2 mRNA translation.The half life of UCP2 protein in the absence of the
mitochondrial reagents was 73min (n=9 independent expe-
riments). Strict comparisons of half life between O2
U− enhanced
and control conditions were inappropriate, because starting
abundances of UCP2 differed and there was evidence for
continuing UCP2 accumulation for up to 30min after addition of
cycloheximide in rotenone and antimycin A-treated cultures.
However, the crude exponential decay rates for UCP2 were
non-significantly reduced in rotenone and DETC-treated
cultures, but not in antimycin-A treated cultures, allowing the
possibility that rotenone and DETC also affected protein
stability. (Fig. 6A). UCP2 therefore accumulates during in-
creased mitochondrial O2
U− production because of increased
translational efficiency and possibly also protein stabilization.
3.6. UCP2 protein accumulation is not through an action of
mitochondrial O2
U− on proteosomal degradation
Because the previous experiments allowed the possibility
that protein stabilization contributed to UCP2 accumulation, we
examined whether this reflected an action of mitochondria-
derived O2
U− on proteosomal degradation. However, blocking
proteosomal function with MG 132 (10μM) did not lead to
UCP2 accumulation and nor did it affect the accumulation
stimulated by rotenone. This indicated that the association
between mitochondrial O2
U− production and UCP2 stabilization
is not through any action on proteosomal degradation (results
not shown).
3.7. UCP2 accumulation is not dependent on mitochondrial
membrane potential
Insertion of the UCP2-related ANT1 protein into the inner
mitochondrial membrane is potential-dependent [41]. Increased
Δψm causes a non-linear increase in mitochondrial O2
U−
generation [42]. We therefore tested whether inner membrane
UCP2 accumulation during mitochondrial O2
U− generation
depended on preservation of Δψm.
Δψm was measured with the potential-dependent mitochon-
drial fluorophore, JC-1, as described in methods. Antimycin A
decreased Δψm in RAW264.7 cells as expected (Fig. 7). UCP2 is
therefore not being recruited to the inner mitochondrial me-
brane, or being retained in it, because of any physicochemical
process that depends on preserved or increased Δψm.
Antimycin A inhibits complex III, which reduces Δψm, but
can also facilitate mitochondrial pore transition to reduce Δψm
[43,44]. Cyclosporin A (1 μM), which blocks mitochondrial
pore transition, did not prevent antimycin A-induced loss of
Δψm (results not shown). This implies that antimycin A was
largely reducing Δψm direct through complex III inhibition in
these experiments.
4. Discussion
Under most circumstances, mitochondria are the most im-
portant source of reactive oxygen species intracellularly, both
physiologically and in pathology. Single electron reduction of
Fig. 6. UCP2 degradation rates are comparable in rotenone-exposed, antimycin A-exposed and unstimulated cultures. (A) When protein synthesis is inhibited with cycloheximide (CHX), UCP2 amounts decline at
comparable rates in cells with normal (closed circles) and increased O2
S− production (open circles), implying that the accumulation during oxidative stress is primarily due to enhanced UCP2 protein synthesis. Cells were
exposed to rotenone, antimycin A or DETC as indicated, for 2 h before stopping protein synthesis. Graphs show mean scanned densities of UCP2 bands in western analyses of RAW264.7 cells exposed to rotenone (n=4),
antimycin A (n=3) and DETC (n=3), versus controls. Preliminary experiments with RAW264.7 extracts showed that scanned density increased linearly with UCP2 protein loading (data not shown). UCP2 continues to
accumulate when protein synthesis is not inhibited (open triangles). (B) Representative western analysis of UCP2 abundance in whole cell extracts of RAW264.7 cells treated with rotenone, DETC or antimycin A, as
described in panel A, with and without cycloheximide.
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Fig. 7. UCP2 accumulation does not depend on preservation or increase of mitochondrial membrane potential. Δψm was measured with the potential-dependent
mitochondrial flurophore, JC-1, after exposure to antimycin A (10 μM) or no treatment. Disappearance of red signal and replacement with green signal corresponds
with loss of Δψm-dependent localisation of the fluorophore in mitochondria. Results are shown as red fluorescence (○) and green fluorescence (▪), normalised to
contemporary controls (upper panels) and as ratios of normalised red signal to normalised green signal, over 30 or 90 m (lower panels). Antimycin A reduced Δψm.
Control experiments showed that the proton ionophore CCCP (10 μM) depolarisedΔψm and the F0F1 ATPase inhibitor, oligomycin (1 μg/ml) hyperpolarisedΔψm, as
expected. Results are means±S.E.M of 6 independent experiments for antimycin A and CCCP and 4 for oligomycin.
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U−, which then may dismute
enzymatically to O2 and H2O2. H2O2 may further reduce in the
presence a transition metal, yielding highly reactive species that
modify lipids, proteins and nucleic acids [11]. O2
U− generated
during activation of mitochondrial pathways of apoptosis
interacts with Fe–sulfur centres in inner mitochondrial mem-
brane respiratory complexes, disrupting electron flow and Δψm
and leading ultimately to transition pore opening, cytochrome
C release and activation of downstream intrinsic pathways of
apoptosis [45]. Although excessive reactive oxygen species
generation is destructive, there is some evidence for regu-
lated production of O2
U− for signaling purposes within the
cell [46].
Mitochondrial production occurs during electron exchange
between coenzyme Q and complexes I and III, at a rate that
varies according to O2 tension, redox status of the NAD(P)H
pool [47] and Δψm [48,49]. Xenobiotics, such as the insecticide
rotenone, that retard electron transfer between complex I or
complex III and coenzyme Q also increase mitochondrial O2
U−
generation. Reactive oxygen species generated in mitochondria
are removed by local superoxide dismutases and peroxidases
and by reaction with low molecular weight reductants and
sulfhydryl-containing protein reductants. Mitochondria contain
both MnSOD and an isoform of Cu/Zn SOD. The effectiveness
of Cu/Zn SOD in clearing O2
U− is revealed by the accumulation
of O2
U− that occurs when it is blocked in mitochondria and
cytosol with DETC (Fig. 1B).
Mechanisms for removal of mitochondrial reactive oxygen
species are thus well described. Additionally, uncoupling pro-
teins lower Δψm and thereby limit ROS production [8,42].UCP2 mRNA is widely distributed in tissue, but mostly without
detectable protein expression, or with low-level constitutive
expression [7]. Abundant constitutive expression of inner
membrane uncoupling proteins, outside the thermoregulatory
function of UCP1 in brown adipose tissue, would be ener-
getically wasteful. However, regulated expression of UCP2
would provide a mechanism for adjusting mitochondrial ROS
production in cell types, such as macrophages, that must
function in widely varying tissue environments. UCP2 protein
is relatively abundant in macrophage lineage cells [7]. A role in
regulating macrophage ROS production has been demonstrated
[8].
In these studies, we observed that UCP2 has a short half life
in macrophages of around 1 h. Similarly rapid elimination has
been documented in mammalian cells overexpressing UCP2
and in yeast cells engineered to express the protein [50]. UCP2
is regulated in macrophages, increasing rapidly in response to a
range of stimuli that increased mitochondrial O2
U− generation.
UCP2 is nuclear encoded and synthesized on cytosolic ribo-
somes before import into mitochondria [51,52]. Transcriptional
regulation of ucp2 has been described for PPAR ligands [53,54]
and lipopolysaccharide [23], but we did not find evidence for
increased ucp2 gene transcription in response to mitochondrial
O2
U− generation. mRNA stabilization was also excluded as a
explanation by observing that UCP2 mRNA abundance did not
increase when UCP2 protein increased.
UCP2 protein abundance poorly reflects mRNA abundance
in tissue, implying important regulatory functions in transla-
tion or protein stability [6]. There is evidence for regulation
of translation through regions in the untranslated exon 2, me-
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heterogenous nuclear ribonucleoprotein K (hnRNPK), which
has activities in translational regulation, has been shown to
bind to sequences in UCP2 mRNA 3′ UTR in yeast 3-hybrid
screening. The complex is found in association with both
polysomes and mitochondria in cultured rat hepatoma cells
[35]. Insulin induction of UCP2 protein in hepatoma cells is
enhanced by hnRNPK expression [35], implying that it is
translationally-mediated. Our observation, that rotenone failed
to further enhance UCP2 abundance after protein synthesis
was interrupted with cycloheximide, also implies an action of
translation.
Although these experiments indicated that regulation by
reactive oxygen species was primarily translational, there were
non-significant reductions in degradation rate in the presence of
DETC and rotenone, allowing the possibility that UCP2 protein
was also stabilized in the inner mitochondrial membrane during
reactive oxygen species generation. Experiments with the
proteosomal inhibitor MG 132 showed that UCP2 was not a
substrate for the proteosomal pathway, excluding this as a po-
sible pathway of regulation. The pathways of UCP2 degradation
in mitochondria are unknown. The broad specificity mitochon-
drial AAA proteases located on the inner mitochondrial mem-
brane, and active either on the intermembrane space surface
(i-AAA) or the matrix surface (m-AAA), are potential can-
didates [55,56], though they have not been found to be active
against UCP2 overexpressed in yeast [50].
Cell fractionation showed that the newly synthesized UCP2
primarily appeared in a fraction that was enriched for
mitochondria, though may have contained contributions from
other organelles, such as endoplasmic reticulum. UCP2 could
potentially accumulate in mitochondrial through more efficient
recruitment into the organelle and away from cytosolic
pathways of degradation. The mechanism of UCP2 recruitment
to the inner mitochondrial membrane has not been specifically
studied. UCP2 does not have a known targeting sequence.
The related ANT1 protein is recruited to the inner mitochon-
drial membrane through a sequence of interactions with TIM
(Transporter of Inner Membrane) proteins, firstly with a com-
plex of Tim9p and Tim10p proteins in the intermembrane space
and then with Tim proteins already resident in the inner
mitochondrial membrane. There is evidence that redox status
influences both stages [41,57] and that Δψm regulates retention
in the inner mitochondrial membrane [52,58]. We can conclude
that recruitment of additional UCP2 to the inner mitochondrial
membrane does not require increased Δψm, because it occurs
with antimycin A, which reduces Δψm.
In these experiments, induction of UCP2 correlated strictly
with increased mitochondrial O2
U− production. We did not prove
that other cellular source of O2
U− could not induce UCP2, but
observed that neither O2
U− generated at the cell surface NAD(P)
H oxidase nor O2
U− generated by redox-cycling of DMNQ in
cytosol and extracellularly [40] induced UCP2. This may reflect
the short diffusion distance of reactive O2
U− or the presence of
cytosolic Cu/Zn SOD. Our experiments do not reveal how
mitochondrial UCP2 regulation is isolated from changes in
extra-mitochondrial ROS levels. Isolation would prevent inci-dental changes in extra-mitochondrial ROS levels from com-
promising the efficiency of mitochondrial energy metabolism
by modifying UCP2 abundance.
These findings extend our understanding of the homeostatic
function of UCP2 in regulating mitochondrial reactive oxygen
production by identifying the afferent limb of a feedback loop
that senses mitochondrial reactive oxygen production, and
increases inner mitochondrial membrane expression of UCP2.
UCP2 diminishes mitochondrial ROS production in macro-
phages [8,23].
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